International Cancer Center & CAR-T Therapy

Cutting-edge oncology care for international patients — including China's leading CAR-T cell therapy program

🩹

Advanced Cancer Care with a Human Touch

The Jiahui International Cancer Center brings together world-class oncologists, cutting-edge technology, and a patient-centered philosophy — all within a JCI-accredited environment.

  • First hospital in China to complete CAR-T therapy for a foreign patient (2023)
  • Designated CAR-T treatment center by Shanghai Huimin Insurance
  • Multidisciplinary team (MDT) approach for every case
  • Full spectrum: chemotherapy, radiation, immunotherapy, surgery, and targeted therapy
  • English-speaking oncologists with international training

Our Cancer Services

Comprehensive oncology care covering the full patient journey.

🩹

CAR-T Cell Therapy

Chimeric Antigen Receptor T-cell therapy for relapsed/refractory blood cancers — multiple myeloma, lymphoma, leukemia. China pioneer with proven results.

💉

Medical Oncology

Chemotherapy, targeted therapy, hormonal therapy, and immunotherapy. Personalized treatment plans based on genetic profiling.

⚡

Radiation Oncology

Precision radiotherapy including IMRT, IGRT, and SBRT. Minimizing damage to healthy tissue while maximizing tumor control.

⚕️

Surgical Oncology

Minimally invasive and robotic-assisted cancer surgeries. Breast, colorectal, liver, lung, and thyroid cancer surgical expertise.

👥

Multidisciplinary Care

Weekly tumor board meetings where oncologists, surgeons, radiologists, and pathologists collaborate on your case.

🌎

International Second Opinion

Remote written or video consultation with our oncology team before you travel. Get clarity on your options from anywhere in the world.

CAR-T Therapy at Jiahui

What makes our CAR-T program stand out for international patients?

Milestone: First Foreign Patient Successfully Treated (2023)

In late 2023, a foreign national with relapsed/refractory multiple myeloma completed CAR-T therapy at Jiahui and achieved remission — marking a historic first for China's medical tourism sector.

What is CAR-T?

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary immunotherapy that engineers your own immune cells to recognize and attack cancer. It has shown remarkable results in blood cancers where other treatments have failed.

Conditions We Treat with CAR-T

  • Multiple Myeloma
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • Follicular Lymphoma
  • Mantle Cell Lymphoma

Why Choose Jiahui for CAR-T?

  • Proven track record: Successfully treated international patients
  • Insurance recognition: Designated by Shanghai Huimin Insurance
  • Full-service support: From visa to discharge, our international team handles everything
  • Cost advantage: CAR-T therapy at Jiahui is significantly more affordable than in the US or Europe

Get a Cancer Treatment Assessment

Share your diagnosis and medical history. Our oncology team will review and provide a preliminary assessment within 48 hours.

Request Oncology Consultation